Literature DB >> 35283114

Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.

Thomas J Velenosi1, Gil Ben-Yakov2, Maren C Podszun2, Julian Hercun3, Ohad Etzion3, Shanna Yang4, Cathy Nadal3, Vanessa Haynes-Williams3, Wen-Chun A Huang3, Lila González-Hódar2, Robert J Brychta5, Shogo Takahashi1, Vikas Akkaraju1, Kristopher W Krausz1, Mary Walter6, Hongyi Cai7, Peter J Walter7, Ranganath Muniyappa5, Kong Y Chen5, Frank J Gonzalez1, Yaron Rotman8.   

Abstract

BACKGROUND & AIMS: Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD.
METHODS: In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model.
RESULTS: There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids.
CONCLUSIONS: We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state. Published by Elsevier Inc.

Entities:  

Keywords:  Diacylglycerols; Lipidomics; Mixed Meal; NAFLD; Postprandial Lipids

Mesh:

Substances:

Year:  2022        PMID: 35283114      PMCID: PMC9117487          DOI: 10.1053/j.gastro.2022.03.004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   33.883


  41 in total

1.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

Authors:  Elisa Fabbrini; B Selma Mohammed; Faidon Magkos; Kevin M Korenblat; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

2.  Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects.

Authors:  Faidon Magkos; Xiong Su; David Bradley; Elisa Fabbrini; Caterina Conte; J Christopher Eagon; J Esteban Varela; Elizabeth M Brunt; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2012-03-13       Impact factor: 22.682

3.  The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.

Authors:  Panu K Luukkonen; Sami Qadri; Tiina E Lehtimäki; Anne Juuti; Henna Sammalkorpi; Anne K Penttilä; Antti Hakkarainen; Marju Orho-Melander; Johanna Arola; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

4.  TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.

Authors:  Giovanni Musso; Ugo Cipolla; Maurizio Cassader; Silvia Pinach; Francesca Saba; Franco De Michieli; Elena Paschetta; Daria Bongiovanni; Luciana Framarin; Nicola Leone; Mara Berrutti; Floriano Rosina; Stefania Corvisieri; Federica Molinaro; Antonio Sircana; Roberto Gambino
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

5.  Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed state.

Authors:  Richard B Heath; Fredrik Karpe; Ross W Milne; Graham C Burdge; Stephen A Wootton; Keith N Frayn
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-11-07       Impact factor: 4.310

6.  Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.

Authors:  Youngae Jung; Min Kyung Lee; Puneet Puri; Bo Kyung Koo; Sae Kyung Joo; Seo Young Jang; Dong Hyeon Lee; Yong Jin Jung; Byeong Gwan Kim; Kook Lae Lee; Tae-Sik Park; Ki-Tae Kang; Do Hyun Ryu; Sang Won Kang; Donghee Kim; Sohee Oh; Won Kim; Geum-Sook Hwang
Journal:  Aliment Pharmacol Ther       Date:  2020-09-06       Impact factor: 8.171

7.  Lipid signature of advanced human carotid atherosclerosis assessed by mass spectrometry imaging.

Authors:  Astrid M Moerman; Mirjam Visscher; Nuria Slijkhuis; Kim Van Gaalen; Bram Heijs; Theo Klein; Peter C Burgers; Yolanda B De Rijke; Heleen M M Van Beusekom; Theo M Luider; Hence J M Verhagen; Antonius F W Van der Steen; Frank J H Gijsen; Kim Van der Heiden; Gijs Van Soest
Journal:  J Lipid Res       Date:  2021-01-06       Impact factor: 5.922

8.  Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice.

Authors:  Abudukadier Abulizi; Daniel F Vatner; Zhang Ye; Yongliang Wang; Joao-Paulo Camporez; Dongyan Zhang; Mario Kahn; Kun Lyu; Alaa Sirwi; Gary W Cline; M Mahmood Hussain; Patricia Aspichueta; Varman T Samuel; Gerald I Shulman
Journal:  J Lipid Res       Date:  2020-09-09       Impact factor: 5.922

9.  Advantages of Studying the Metabolome in Response to Mixed-Macronutrient Challenges and Suggestions for Future Research Designs.

Authors:  Jennifer L LaBarre; Kanakadurga Singer; Charles F Burant
Journal:  J Nutr       Date:  2021-10-01       Impact factor: 4.687

10.  Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2.

Authors:  Zehra Irshad; Nikola Chmel; Raghu Adya; Victor A Zammit
Journal:  J Lipid Res       Date:  2018-11-05       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.